Cell migration is a fundamental process required for embryogenesis, angiogenesis, wound healing and immune responses, and abnormalities in this process are associated with a plethora of pathological conditions including autoimmune diseases, arthrosclerosis and tumor metastasis. Cell migration is regulated by chemoattractants acting on cell-surface receptors belonging to the large family of G protein-coupled receptors. These receptors typically couple to G proteins of the Gi/o class, and mediate their functions through Gbg dimers. Although the essential role of Gbg in cell migration has been well established, it is still unclear how Gbg activate downstream effectors to generate a highly polarized intracellular signal that acts as an internal """"""""compass"""""""" to drive directional cell migration. We have recently identified novel interactions between Gbg and the WD40 repeat proteins RACK1 (receptor for activated C kinase 1) and WDR26. Based on the findings that RACK1 and WDR26 are localized at the leading edge of a polarized leukocyte and negatively and positively regulate Gbg signaling, respectively, we hypothesize that reciprocal interactions of Gbg with WDR26 and RACK1 are important positive and negative feedback regulations for the coordinated Gbg signaling at the leading edge that drives leukocyte polarization and directed migration.
In Aim 1, we will explore the molecular mechanism by which WDR26 interacts with Gbg and its effectors including PI3Ks and PLCb to promote Gbg signaling and generate a highly polarized intracellular response at the leading edge for leukocyte migration.
In Aim 2, we will determine how RACK1 restricts Gbg signaling for the generation of a locally amplified signal at the leading edge and for signal adaptation and directional sensing. Finally, we will dissect the molecular signals that control the reciprocal interactions of WDR26 and RACK1 with Gbg and determine the impact of the balance of these interactions on leukocyte migration. These studies have the potential to close a critical gap in our understanding of how chemoattractants transmit through Gbg to generate a spatially localized cellular signal at the leading edge that drives leukocyte migration, and to unveil a novel mechanism of regulating chemotaxis at the level of G proteins upstream to all known signaling pathways essential for cell migration. Given the involvement of abnormal leukocyte migration in many pathological conditions, the proposed research will be vital for identifying novel targets to enable selective interference of the signaling pathways related to disease development. Thus, this work has high biological significance and potential impact on human health.

Public Health Relevance

This application proposes to study the mechanisms underlying leukocyte migration. The study is expected to contribute significantly to the development of new therapies for the treatment of diseases related to abnormal leukocyte migration including autoimmune diseases, cardiovascular diseases and tumor metastasis.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
1R01GM094255-01A1
Application #
8105776
Study Section
Nuclear and Cytoplasmic Structure/Function and Dynamics Study Section (NCSD)
Program Officer
Deatherage, James F
Project Start
2011-09-30
Project End
2016-08-31
Budget Start
2011-09-30
Budget End
2012-08-31
Support Year
1
Fiscal Year
2011
Total Cost
$286,900
Indirect Cost
Name
University of Iowa
Department
Pharmacology
Type
Schools of Medicine
DUNS #
062761671
City
Iowa City
State
IA
Country
United States
Zip Code
52242
Ke, Wenfan; Ye, Ding; Mersch, Kacey et al. (2017) G?1 is required for neutrophil migration in zebrafish. Dev Biol 428:135-147
Paudyal, Prakash; Xie, Qing; Vaddi, Prasanna Kuma et al. (2017) Inhibiting G protein ?? signaling blocks prostate cancer progression and enhances the efficacy of paclitaxel. Oncotarget 8:36067-36081
Ye, Yuanchao; Tang, Xiaoyun; Sun, Zhizeng et al. (2016) Upregulated WDR26 serves as a scaffold to coordinate PI3K/ AKT pathway-driven breast cancer cell growth, migration, and invasion. Oncotarget 7:17854-69
Xie, Qing; Klesney-Tait, Julia; Keck, Kathy et al. (2015) Characterization of a novel mouse model with genetic deletion of CD177. Protein Cell 6:117-26
Ye, Yuanchao; Sun, Zhizeng; Guo, Ang et al. (2014) Ablation of the GNB3 gene in mice does not affect body weight, metabolism or blood pressure, but causes bradycardia. Cell Signal 26:2514-20
Xu, Hui; Ye, Ding; Behra, Martine et al. (2014) G?1 controls collective cell migration by regulating the protrusive activity of leader cells in the posterior lateral line primordium. Dev Biol 385:316-27
Sun, Zhizeng; Smrcka, Alan V; Chen, Songhai (2013) WDR26 functions as a scaffolding protein to promote G??-mediated phospholipase C ?2 (PLC?2) activation in leukocytes. J Biol Chem 288:16715-25
Runne, Caitlin; Chen, Songhai (2013) PLEKHG2 promotes heterotrimeric G protein ??-stimulated lymphocyte migration via Rac and Cdc42 activation and actin polymerization. Mol Cell Biol 33:4294-307
Runne, Caitlin; Chen, Songhai (2013) WD40-repeat proteins control the flow of G?? signaling for directional cell migration. Cell Adh Migr 7:214-8
Xu, Hui; Kardash, Elena; Chen, Songhai et al. (2012) G?? signaling controls the polarization of zebrafish primordial germ cells by regulating Rac activity. Development 139:57-62

Showing the most recent 10 out of 12 publications